Building Your Early Phase Clinical Trial Data, From Protocol to Regulatory Submission

Phase I clinical trials involve a complex, multi-step data journey that require quality, reliable data if aiming to achieve successful drug development. From the initial preclinical data, the plan to bring a drug to market is built upon the foundation of solid, reliable data that demonstrates safety in human patient population.

Discover what best practices and approaches can help to mitigate challenges, from issues with conceptualization and initial protocol development, to collection and analysis, and even final regulatory submission. Listeners will also learn how integration and collaboration build the strongest datasets in drug development programs.